Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study
Journal of Clinical Medicine Research · 2026-11 · 18 (11) · 815-822
DOI: 10.14740/jocmr6733 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine Research, 2026-11. Verfasst von Masato Habuka und 4 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Habuka, M., Otsuka, S., Satokata, K., Ogawa, A., & Yamamoto, S. (2026). Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study. Journal of Clinical Medicine Research, 18(11), 815-822. https://doi.org/10.14740/jocmr6733
Vancouver
Habuka M, Otsuka S, Satokata K, Ogawa A, Yamamoto S. Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study. Journal of Clinical Medicine Research. 2026;18(11):815-822. doi:10.14740/jocmr6733
BibTeX
@article{Habuka2026,
author = {Habuka, Masato and Otsuka, Sahoko and Satokata, Kazunori and Ogawa, Asa and Yamamoto, Suguru},
title = {Urate-Lowering Effect of Dotinurad During Concomitant Sodium-Glucose Cotransporter 2 Inhibitor Therapy for Chronic Kidney Disease: A Retrospective Study},
journal = {Journal of Clinical Medicine Research},
year = {2026},
volume = {18},
number = {11},
pages = {815--822},
doi = {10.14740/jocmr6733}
}
EUVIMED